Lisheng Liu

Active 1994–2025

88
Papers
32,801
Citations
61
h-index
79
i10-index

Citations

Citations per year for Lisheng Liu1967: 1 citations1985: 1 citations1995: 1 citations1997: 2 citations1998: 2 citations1999: 8 citations2000: 18 citations2001: 50 citations2002: 54 citations2003: 58 citations2004: 47 citations2005: 41 citations2006: 41 citations2007: 78 citations2008: 95 citations2009: 209 citations2010: 197 citations2011: 198 citations2012: 205 citations2013: 226 citations2014: 227 citations2015: 281 citations2016: 299 citations2017: 354 citations2018: 285 citations2019: 1,030 citations2020: 926 citations2021: 833 citations2022: 725 citations2023: 488 citations2024: 763 citations2025: 327 citations2026: 19 citations1968–1984: no citations, so these years are not shown1986–1994: no citations, so these years are not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,693 citing papers, 16.9% of this breakdownChina: 1,746 citing papers, 11% of this breakdownUnited Kingdom: 1,275 citing papers, 8% of this breakdownCanada: 748 citing papers, 4.7% of this breakdownAustralia: 642 citing papers, 4% of this breakdownItaly: 630 citing papers, 4% of this breakdownGermany: 501 citing papers, 3.2% of this breakdownFrance: 395 citing papers, 2.5% of this breakdownSweden: 373 citing papers, 2.3% of this breakdownNetherlands: 371 citing papers, 2.3% of this breakdownJapan: 366 citing papers, 2.3% of this breakdownIndia: 362 citing papers, 2.3% of this breakdown
0%16.9%Other 36.5%

Fields

  • Medicine78.1%
  • Biochemistry, Genetics and Molecular Biology8.6%
  • Nursing3.4%
  • Neuroscience1.7%
  • Health Professions1.6%
  • Engineering0.8%
  • Other5.8%

Topics

  • Blood Pressure and Hypertension Studies6%
  • Diabetes Treatment and Management4.9%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4%
  • Acute Ischemic Stroke Management3.8%
  • Diabetes Management and Research2.8%
  • Sodium Intake and Health2.4%
  • Other76.1%

Coauthors

All papers

Open in search
  1. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 7,418

  2. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aytekin Oğuz, Xingyu Wang, Ernesto Peñaherrera, Fernando Laņas, Okechukwu S. Ogah, Adesola Ogunniyi, Helle K. Iversen, Germán Málaga, Zvonko Rumboldt, Shahram Oveisgharan, F Hussain, Daliwonga Magazi, Yongchai Nilanont, John Ferguson, Guillaume Paré, Salim Yusuf - The Lancet 2016 cited by 2,209

  3. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2010 cited by 3,467

  4. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peggy Gao, Rafael Díaz, Eva Lonn - New England Journal of Medicine 2016 cited by 844

  5. Treatment of Hypertension in Patients 80 Years of Age or Older

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 3,090

  6. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Afzalhussein Yusufali, Roya Kelishadi, Annamarie Kruger, Thandi Puoane, Andrzej Szuba, Jephat Chifamba, Aytekin Oğuz, Matthew McQueen, Martin McKee, Gilles R. Dagenais - New England Journal of Medicine 2014 cited by 995

  7. Hypertension in China: epidemiology and treatment initiatives

    Authors: , , , - Nature Reviews Cardiology 2023 cited by 173

  8. Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fan Fan Hou - JAMA 2015 cited by 737

  9. [2010 Chinese guidelines for the management of hypertension].

    Authors: - 2011 cited by 700

  10. Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Quanyong Xiang, Zhengrong Liu, Yundong Sheng, Jinghua Tang, Lisheng Liu, Salim Yusuf, Wei Li - European Heart Journal 2022 cited by 156

  11. China cardiovascular diseases report 2018: an updated summary.

    Authors: , , , , , , , , , , , - 2020 cited by 405

  12. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 148

  13. Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 895

  14. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fang Wang, Jinwei Wang, Adeera Levin, Ognjenka Djurdjev, Mila Tang, Hiroyasu Iso, Kazumasa Yamagishi, Mitsumasa Umesawa, Isao Muraki, Masafumi Fukagawa, Shoichi Maruyama, Takayuki Hamano, Takeshi Hasegawa, Naohiko Fujii, David C. Wheeler, John Emberson, John Townend, Martin Landray, Jamie Green, H. Lester Kirchner, Alex R. Chang, Massimo Círillo, Sun Ha Jee, Heejin Kimm, Yejin Mok, Gabriel Chodick, Varda Shalev, Jack F.M. Wetzels, Peter J. Blankestijn, Arjan D. van Zuilen, Michael Bots, Mark J. Sarnak, Lesley Inker, Dorothea Nitsch, Paul Roderick, Astrid Fletcher, Erwin Böttinger, Girish N. Nadkarni, Stephen B. Ellis, Rajiv Nadukuru, Yingying Sang, Nigel J. Brunskill, Rupert Major, David Shepherd, James Medcalf, Ron T. Gansevoort, Stephan J. L. Bakker, Hiddo J.L. Heerspink, Simerjot K Jassal, Jaclyn Bergstrom, Joachim H. Ix, Elizabeth Barrett‐Connor, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Hiddo J.L. Heerspink, Dick de Zeeuw, Barry M. Brenner, Juan Jesús Carrero, Alessandro Gasparini, Carl‐Gustaf Elinder, Peter Bárány, Marie Evans, Mårten Segelmark, Maria Stendahl, Staffan Schön, Navdeep Tangri, Maneesh Sud, David Naimark, Chi-Pang Wen, Chwen-Keng Tsao and 26 more - European Heart Journal 2018 cited by 323

  15. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hyejung Jung, Gilles R. Dagenais, Salim Yusuf - New England Journal of Medicine 2016 cited by 618

  16. Sleep Patterns and the Risk of Acute Stroke

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Romaina Iqbal, Germán Málaga, Antonio Dans, Anna Członkowska, Danuta Ryglewicz, Nana Pogosova, Fawaz Alhussein, L. Devilliers, Amhed Elsayed, Yongchai Nilanont, Aytekin Oğuz, Charles Mondo, Alfzalhussein Yusufali, Peter Langhorne - Neurology 2023 cited by 63

  17. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Dans, Gilles R. Dagenais - New England Journal of Medicine 2016 cited by 375

  18. Association of Psychosocial Stress With Risk of Acute Stroke

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jane DeJesus, Mahshid Dehghan, Steven Agapay, Rafael Díaz, George Varigos, Álvaro Avezum, Lisheng Liu, Hongye Zhang, Patricio López‐Jaramillo, Zvonko Rumboldt, Ernesto Peñaherrera, Hans-Christopher Diener, Prem Pais, Osamah Albaker, Khalid Yusoff, Albertino Damasceno, Okechukwu S. Ogah, Romaina Iqbal, Antonio Dans, Danuta Ryglewicz, Linda de Villiers, Ahmed ElSayed, Yongchai Nilanont, Samart Nidhinandana, Charles Mondo, Alfzalhussein Yusufali - JAMA Network Open 2022 cited by 55

  19. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis

    Authors: , , , , , , , , - The Lancet 2007 cited by 592

  20. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

    Authors: , , , , , , , , , , , , - The Lancet 2000 cited by 1,170

  21. Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Teresa C. Chen, John Chalmers, Mark Woodward, Hisatomi Arima, Vlado Perkovic, Hiroshi Yatsuya, Koji Tamakoshi, Yuanying Li, Yoshihisa Hirakawa, Josef Coresh, Kunihiro Matsushita, Morgan E. Grams, Yingying Sang, Kevan R. Polkinghorne, Steven J. Chadban, Robert C. Atkins, Adeera Levin, Ognjenka Djurdjev, Luxia Zhang, Lisheng Liu, Ming‐Hui Zhao, Fang Wang, Jinwei Wang, Elke Schäeffner, Natalie Ebert, Peter Martus, Adeera Levin, Ognjenka Djurdjev, Mila Tang, Gunnar H. Heine, Insa E. Emrich, Sarah Seiler, Adam M. Zawada, Joseph V. Nally, Sankar D. Navaneethan, Jesse D. Schold, Luxia Zhang, Ming‐Hui Zhao, Fang Wang, Jinwei Wang, Michael G. Shlipak, Mark J. Sarnak, Ronit Katz, Jade S. Hiramoto, Hiroyasu Iso, Kazumasa Yamagishi, Mitsumasa Umesawa, Isao Muraki, Masafumi Fukagawa, Shoichi Maruyama, Takayuki Hamano, Takeshi Hasegawa, Naohiko Fujii, David C. Wheeler, John Emberson, John Townend, Martin Landray, Hermann Brenner, Ben Schöttker, Kai‐Uwe Saum, Dietrich Rothenbacher, Caroline S. Fox, Shih‐Jen Hwang, Anna Köttgen, Florian Kronenberg, Markus P. Schneider, Kai‐Uwe Eckardt, Jamie Green, H. Lester Kirchner, Alex R. Chang and 134 more - American Journal of Kidney Diseases 2018 cited by 94

  22. Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2021 cited by 37

  23. A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists

    Authors: , , , - Pharmacological Reviews 2013 cited by 289

  24. Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial

    Authors: , , , , , , , , , - EBioMedicine 2017 cited by 127